Tackling antimicrobial resistance through two novel methods: repurposing vanoxerine as a novel anti-tubercular drug; and silencing virulence in Pseudomonas aeruginosa through inhibition of PqsR
Publication Date
December 13, 2018
Creator
Abstract
The antimicrobial resistance crisis is one which will persist and worsen without intervention. This thesis looks to explore two innovative research areas in order to develop new antibiotics and stem the rise in antibiotic resistance. The first project looked at the potential to repurpose the former central nervous system (CNS) drug candidate vanoxerine into an anti-tubercular compound. Previous work has suggested that vanoxerine acts as a prodrug in mycobacteria and interacts with the monooxygenase enzymes Rv0565c and Rv3518c of Mycobacterium tuberculosis (Mtb). In this work a MIC50 assay was utilised to complete a structure-activity relationship (SAR) study and prove that vanoxerine is hydroxylated in vivo to its active form. Further to this, a global lipid analysis was completed suggesting that when treated with analogues of vanoxerine a lipid biosynthetic pathway was halted, though the lipid itself could not be identified. Although mass spectrometry was employed to identify changes in lipid concentrations at varying concentrations of drug, no trends were clear. However, the mass spectrometry data did indicate that analogues of vanoxerine were also hydroxylated in vivo, furthering the original hypothesis.
A further novel method for targeting antimicrobial resistance is the targeting of virulence systems. By inhibiting virulence but not affecting cell viability, no selection pressures are put on the pathogenic population. This enables the immune system to clear the infection without the host cells from being harmed by the release of toxins whilst preventing resistant subpopulations from dominating. In this work, a series of compounds were synthesised to act as antagonists to the protein PqsR, the autoinductive regulator of the quorum sensing system pqs in Pseudomonas aeruginosa. This system is associated with a range of effects including the synthesis of the toxin pyocyanin and the biofilm formation. Therefore, interference with these pathways may attenuate P. aeruginosa without encouraging selection of resistant bacteria. A biosensor reporter assay provided semiquantitative data suggesting that the majority of synthesised compounds reduced expression of the pqs system. Moreover, IC50 testing has been initiated, providing quantitative data on the potency of the synthesised series.
Item Type
ethesis
Thesis Type
MRes
Supervisors
Subjects (LC)
Associated Schools / Departments
School of Life Sciences
eprints ID
55397
UoN Repository URI
Except where otherwise noted, this item's license is described as
File(s)![Thumbnail Image]()
Name
Scott Grossman MRes final.pdf
Type
Full-text
Description
Examined
Size
56.36 MB
Format
Adobe PDF
Checksum (MD5)
dd7708abac275f916286098642e9c847